(2R,4S,4aS)-11-Fluoro-8-((S)-3-methoxypyrrolidin-1-yl)-2,4-dimethyl-1,2,4,4a-tetrahydro-2'H,6H-spiro[isoxazolo[4,5-g][1,4]oxazino[4,3-a]quinoline-5,5'-pyrimidine]-2',4',6'(1'H,3'H)-trione

ID: ALA5179981

PubChem CID: 168275107

Max Phase: Preclinical

Molecular Formula: C23H26FN5O6

Molecular Weight: 487.49

Associated Items:

Names and Identifiers

Canonical SMILES:  CO[C@H]1CCN(c2noc3c(F)c4c(cc23)CC2(C(=O)NC(=O)NC2=O)[C@H]2[C@H](C)O[C@H](C)CN42)C1

Standard InChI:  InChI=1S/C23H26FN5O6/c1-10-8-29-16-12(7-23(18(29)11(2)34-10)20(30)25-22(32)26-21(23)31)6-14-17(15(16)24)35-27-19(14)28-5-4-13(9-28)33-3/h6,10-11,13,18H,4-5,7-9H2,1-3H3,(H2,25,26,30,31,32)/t10-,11+,13+,18-/m1/s1

Standard InChI Key:  CPXPEOKQLULRLW-KACXOKKCSA-N

Molfile:  

 
     RDKit          2D

 36 41  0  0  0  0  0  0  0  0999 V2000
   -0.9453    0.2722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2308    0.6845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4810    0.2727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4810   -0.5525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2289   -0.9643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9453   -0.5562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1957    0.6852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9103    0.2726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9103   -0.5525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1957   -0.9650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9103    1.0978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6249    1.5104    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3396    1.0977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3396    0.2726    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6250   -0.1399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6249   -0.9651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6249   -1.7903    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9103   -2.2029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1957   -1.7903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7332    0.5282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7333   -0.8121    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2202   -0.1418    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9468    1.3253    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7168    1.6209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6736    2.4446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8769    2.6581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4278    1.9663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9103   -1.3777    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    3.3396   -0.5525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9103   -3.0281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1957    1.5104    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0542    1.5104    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0376   -0.8545    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2289   -1.7894    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2572    3.0281    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0542    2.8145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  3  7  1  0
  8  7  1  0
  9  8  1  0
 10  9  1  0
  4 10  1  0
  8 11  1  0
 12 11  1  0
 13 12  1  0
 14 13  1  0
 15 14  1  0
  8 15  1  0
  9 16  1  0
 17 16  1  0
 18 17  1  0
 19 18  1  0
 10 19  1  0
  1 20  1  0
  6 21  1  0
 21 22  1  0
 22 20  2  0
 20 23  1  0
 24 23  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 23  1  0
  9 28  1  6
 16 29  1  6
 18 30  1  6
 11 31  2  0
 13 32  2  0
 15 33  2  0
  5 34  1  0
 25 35  1  1
 35 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5179981

    ---

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

gyrB DNA gyrase subunit A/DNA gyrase subunit B (505 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 487.49Molecular Weight (Monoisotopic): 487.1867AlogP: 1.08#Rotatable Bonds: 2
Polar Surface Area: 126.24Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.31CX Basic pKa: 1.33CX LogP: 1.56CX LogD: 1.22
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.60Np Likeness Score: -0.29

References

1. Govender P, Müller R, Singh K, Reddy V, Eyermann CJ, Fienberg S, Ghorpade SR, Koekemoer L, Myrick A, Schnappinger D, Engelhart C, Meshanni J, Byl JAW, Osheroff N, Singh V, Chibale K, Basarab GS..  (2022)  Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis Activity.,  65  (9.0): [PMID:35500229] [10.1021/acs.jmedchem.2c00266]

Source